Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for neurogenic detrusor overactivity
2005-003068-47Phase 3Completed
- Sponsor
- Region Skåne
- Start
- Jul 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-arm trial of botulinum toxin type A in detrusor hyperreflexia (DH) and neurogenic bladder, sponsored by Region Skåne. Primary endpoint: Number of voids per 24 hours. Started Jul 2005; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
detrusor hyperreflexia (DH)neurogenic bladder
Beyond the preview
Go deeper on 2005-003068-47.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003068-47.